SPY401.72+9.38 2.39%
DIA322.23+4.59 1.45%
IXIC11,805.00+434.04 3.82%

BRIEF-FDA - FDA, CDC, State,Local Partners Are Investigating Consumer Complaints And/Or Reports Of Infant Illness, Got Related To Products From Abbott Nutrition’S Sturgis Facility

reuters.com · 04/29/2022 16:37
BRIEF-FDA - FDA, CDC, State,Local Partners Are Investigating Consumer Complaints And/Or Reports Of Infant Illness, Got Related To Products From Abbott Nutrition’S Sturgis Facility

- FDA:

  • FDA - FDA, CDC, STATE,LOCAL PARTNERS ARE INVESTIGATING CONSUMER COMPLAINTS AND/OR REPORTS OF INFANT ILLNESS, GOT RELATED TO PRODUCTS FROM ABBOTT NUTRITION’S STURGIS FACILITY

  • FDA- FOUR ILL PATIENTS ARE REPORTED TO HAVE CONSUMED POWDERED INFANT FORMULA PRODUCED FROM ABBOTT NUTRITION’S STURGIS, MI, FACILITY

  • FDA- ABBOTT HAS CONFIRMED WITH FDA THAT CO WILL CONSIDER RELEASE OF PRODUCTS FROM ABBOTT NUTRITION’S STURGIS, MI, FACILITY ON A CASE-BY-CASE BASIS

  • FDA - INFORMED ABBOTT IT HAS NO OBJECTION TO IMMEDIATELY RELEASING PRODUCT FOR SUPPLY OF SPECIALTY, METABOLIC FORMULAS ON A CASE-BY-CASE BASIS

Source text for Eikon: [ID:]

Further company coverage: [ ]


((Reuters.Briefs@thomsonreuters.com;))